A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Johns Hopkins Hospital, Baltimore

The University of North Carolina at Chapel Hill, Chapel Hill

Hopital Pitie-Salpetriere, Paris

Hospital Europeen Georges Pompidou, Paris

UCSD Treatment Center, San Diego

Hospital Clinico de Barcelona, Barcelona

Ciutat Sanitaria de Bellvitge, Barcelona